Abstract

Molecular diversity as a source of potential drug candidates has been an area of tremendous growth during the past year. The field has been dominated by investigations featuring diverse peptide libraries, generated by both chemical and biological methods. Yet the many undesirable properties of peptides as drugs, such as poor oral availability and low in vivo stability, have prompted chemists to develop methods for the efficient synthesis of conformationally constrained peptide, biopolymer and non-polymeric compound collections.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.